These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of captopril on intracellular free calcium ([Ca2+]i) of thymocytes in spontaneously hypertensive rats.
    Author: Xie L, Chen D, Wu D, Wang H.
    Journal: J Hum Hypertens; 1996 Jun; 10(6):425-7. PubMed ID: 8872812.
    Abstract:
    Hypertension is associated with dysfunction of the immune system. Intracellular free calcium ([Ca2+]i) was reportedly increased in immune cells, such as lymphocytes and thymocytes, both in hypertensive patients and in animals. To evaluate if captopril has an effect on the immune system, [Ca2+]i in thymocytes was monitored during the development of hypertension from 4-24 weeks, and after treatment with captopril for 4 and 12 weeks in spontaneously hypertensive rats (SHR). SHR (n = 24) were treated with captopril at a dose of 20 mg/kg/day at 12 weeks of age after establishment of hypertension. Untreated SHR (n = 17) and normotensive Wistar Kyoto (WKY n = 14) served as control. [Ca2+]i of thymocytes was measured using Fura-2. It was found that [Ca2+]i of thymocytes decreased both in SHR and WKY from 4-12 weeks of age. From 12-24 weeks, [Ca2+]i in thymocytes remained at a constant level in WKY. However, [Ca2+]i in thymocytes increased significantly in SHR after 12 weeks. Captopril (CAP) treatment significantly lowered [Ca2+]i in thymocytes derived from SHR at 24 weeks. This treatment was associated with a moderate reduction in systolic blood pressure. Established hypertension in SHR is associated with increased [Ca2+]i in thymocytes. This may be indicative of immunological dysfunction. Captopril inhibits the increase in [Ca2+]i of thymocytes in SHR.
    [Abstract] [Full Text] [Related] [New Search]